Detection of peptide-specific CTL-precursors in peripheral blood lymphocytes of cancer patients

Development of therapeutic vaccines is one of the major areas of tumour immunotherapy today. However, clinical trials of peptide-based cancer vaccines have rarely resulted in tumour regression. This failure might be due to an insufficient induction of cytotoxic T lymphocytes in the current regimes,...

Descripción completa

Detalles Bibliográficos
Autores principales: Maeda, Y, Hida, N, Niiya, F, Katagiri, K, Harada, M, Yamana, H, Kamura, T, Takahashi, M, Sato, Y, Todo, S, Itoh, K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364263/
https://www.ncbi.nlm.nih.gov/pubmed/12232766
http://dx.doi.org/10.1038/sj.bjc.6600548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364263/
https://www.ncbi.nlm.nih.gov/pubmed/12232766
http://dx.doi.org/10.1038/sj.bjc.6600548

Ejemplares similares